Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
Orion to receive an upfront payment of USD 290 million
Advancing to IND-enabling studies with multiple drug candidates
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Subscribe To Our Newsletter & Stay Updated
